Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 280: C1657-C1668, 2001;
0363-6143/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamm-Alvarez, S. F.
Right arrow Articles by Ann, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamm-Alvarez, S. F.
Right arrow Articles by Ann, D. K.
Vol. 280, Issue 6, C1657-C1668, June 2001

SPECIAL TOPIC
Etk/Bmx activation modulates barrier function in epithelial cells

Sarah F. Hamm-Alvarez1,3, Allen Chang2,*, Yanru Wang1,*, Galina Jerdeva1, H. Helen Lin2, Kwang-Jin Kim2,3,4,5,6, and David K. Ann2,7

Departments of 1 Pharmaceutical Sciences, 2 Molecular Pharmacology and Toxicology, 3 Physiology and Biophysics, 4 Biomedical Engineering, and 5 Medicine, 6 Will Rogers Institute Pulmonary Research Center, and 7 Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, California 90033


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Etk/Bmx is a member of the Tec family of cytoplasmic non-receptor tyrosine kinases known to express in epithelial cells. We demonstrate herein that Etk activation in stably Etk-transfected epithelial Pa-4 cells resulted in a consistently increased transepithelial resistance (TER). After 24 h of hypoxic (1% O2) exposure, the TER and equivalent active ion transport rate (Ieq) were reduced to <5% of the normoxia control in Pa-4 cells, whereas both TER and Ieq were maintained at comparable and 60% levels, respectively, relative to their normoxic controls in cells with Etk activation. Moreover, Pa-4 cells exhibited an abundant actin stress fiber network with a diffuse distribution of beta -catenin at the cell periphery. By contrast, Etk-activated cells displayed a redistribution of actin to an exclusively peripheral network, with a discrete band of beta -catenin also concentrated at the cell periphery, and an altered occludin distribution profile. On the basis of these findings, we propose that Etk may be a novel regulator of epithelial junctions during physiological and pathophysiological conditions.

signal transduction; adaptive response


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

AN IMPORTANT CHARACTERISTIC of the epithelium is that it forms a functional barrier to prevent the permeation of noxious agents to the internal milieu and, at the same time, to allow passive vectorial transepithelial transport of nutrients, electrolytes, and small solutes. Several disease-associated states, such as ischemic and hypoxic injuries, effectively disrupt the permeability barrier as well as enhance the movement of ions, large solutes, and inflammatory cells across tight epithelial structures (7, 13, 17, 24, 48). Hence, a better understanding of the mechanism underlying the regulation of epithelial barrier function is of potential physiological and pharmacological significance. Although the structure and function of junctional barriers have been extensively studied, the molecular signaling pathways that modulate assembly, disassembly, and maintenance of junctional integrity under various health and disease states appear to be multifactorial and rather complex.

The epithelium contains at least four classes of intercellular junctions: tight junctions (TJs), adherens junctions (AJs), desmosomes, and gap junctions. Among these classes, TJs are the most critical in forming barriers to the diffusion of solute through the paracellular pathway, whereas AJs play a key role in the formation of tight junctions (10). TJs are also essential for the polarization of epithelial cells, since they form a boundary between apical and basolateral plasma membrane domains. Structurally, TJs comprise several transmembrane proteins, such as occludin and members of the claudin family, and peripheral membrane proteins, such as zonula occludens (ZO)-1, ZO-2, ZO-3, cingulin, 7H6, and symplekin (15). The peripheral membrane protein ZO-1 binds to actin filaments, directly or through a linking protein, serving thus as a candidate for coupling perijunctional actin to the paracellular barrier (15). The basic components of AJs in epithelial cells include transmembrane protein E-cadherin and the cytoplasmic proteins alpha -, beta -, and gamma -catenins, which link E-cadherin to the actin cytoskeleton (9, 21). Among them, E-cadherin is responsible for the correct establishment and maintenance of AJs through a Ca2+-dependent homophilic interaction with adjacent cells. Blocking the function of E-cadherin results in a destruction of AJs and subsequent disassembly of TJs (31). On the other hand, catenins tether the cadherin complexes to actin cytoskeleton and have often been investigated as potential cytoplasmic targets for regulation of AJs (19). Together, the expression and modification of these TJ and AJ molecules determine the permeability properties of epithelial barriers toward hydrophilic solutes and plasticity of intercellular junctions.

In addition to the structural interdependence between TJs and AJs, agents that disrupt the actin cytoskeleton can also lead to the disassembly of TJs (2, 22). This observation is consistent with a model in which the establishment of appropriate actin cytoarchitecture is a key factor in the formation of TJs (15). This notion is further supported by the observation that TJs appear to be tethered to the actin filaments (12). Hence, both actin filaments and AJs appear to participate directly or indirectly in the formation and/or maintenance of TJs. While AJ complexes are primarily involved in maintaining cell-cell adhesions between adjacent epithelial cells, TJ structures modulate epithelial barrier function and paracellular permeability.

The results from many laboratories have suggested that a complex set of signal transduction pathways is likely to target and control the junctional properties of epithelial cells. The barrier function of TJs is reportedly influenced by growth factors, extra- and intra-cellular Ca2+ levels, protein kinase C, receptor and non-receptor tyrosine kinases, and phospholipase C in different types of epithelial cells (3, 4, 6, 16, 19, 27, 28, 42, 54, 55). In terms of AJs, significant tyrosine phosphorylation of beta -catenin, gamma -catenin, and p120-catenin is detected in proliferating epithelial cells (35). As epithelial cells reach confluence and undergo the process of contact inhibition, tyrosine phosphorylation of catenins decreases. This observed decrease in tyrosine phosphorylation is correlated with an increased tyrosine phosphatase activity (5, 11). Many receptor and non-receptor tyrosine phosphatases have been coimmunoprecipitated with cadherin-catenin complexes. Thus components of TJs, AJs, plasma membranes, and cytoskeleton are all potential targets for these already-identified or to-be-identified kinases and phosphatases. The biochemical basis of these modulations by signaling molecules is only beginning to be unraveled. The focus of this study is the characterization of the effects of a novel epithelial tyrosine kinase, Etk, on paracellular permeability and junctional protein complexes of a model epithelial barrier, Pa-4.

Etk, also named Bmx, belongs to a new class of cytoplasmic non-receptor tyrosine kinases, Btk/Tec, members of which are expressed in both hematopoietic and nonhematopoietic cells. This family consists of Btk (46, 50), Itk (18, 39), Tec (30), and Etk/Bmx (34, 43) tyrosine kinases, which share homologous structures, including the NH2-terminal pleckstrin homology (PH) domain, followed by Tec homology (TH), Src homology (SH) 3, SH2, and tyrosine kinase domains. These Tec kinases have been demonstrated to participate in signaling pathways involving a variety of cytokine receptors and antigen receptors. Etk, unlike other members of the Tec family kinases that are mostly hematopoietic cell specific, is preferentially expressed in epithelial cells (34). We have previously demonstrated that Etk directly activates signal transducer and activator of transcription (STAT) 1, STAT3, and STAT5 in salivary epithelial cells by using an estrogen (E2)-inducible Etk construct (52). To date, the precise biological function of Etk in epithelial cells has not been defined.

To better understand the molecular nature of salivary epithelial cellular responses to the activation of Etk, we have established a model system by stably transfecting rat salivary epithelial Pa-4 cells with an inducible Etk-estrogen receptor (ER) chimeric construct (Delta Etk:ER), which is activated in cells by the ER ligand, beta -estradiol. Through a combined approach in search of Etk-mediated biological events, we identify here a series of effects of Etk on transepithelial resistance (TER) in parallel with components of AJs and TJs. We have demonstrated that Etk activation is sufficient to elicit an increase in TER, a common gauge of junctional tightness between epithelial cells, and have further shown that this increase was sustained in response to hypoxic challenge. The increased TER elicited by Etk activation was accompanied by changes in actin filaments organization and in the recruitment and/or changes in protein properties of several peripheral and integral membrane proteins involved in TJ and AJ regulation. Together, we postulate that the functional and biochemical modulation of TJ and AJ during normoxia and hypoxia appears to be dependent on an Etk-mediated signaling cascade. Moreover, our results shown herein suggest that the cells with stable expression of Delta Etk:ER represent a unique and useful tool to elucidate the role of Etk in modulating TJ/AJ assembly/disassembly and subsequent responses to hypoxic challenge in salivary epithelial cells as well as in other cell types. These observations are significant in understanding the physiological regulation of epithelial permeability and discerning the mechanism leading to epithelial permeability dysfunction(s) associated with many disease states.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents. Rhodamine-phalloidin, phenylmethylsulfonyl fluoride (PMSF), aprotinin, pepstatin A, N-tosyl-L-phenylalanine chloromethyl ketone, leupeptin, N-alpha -p-tosyl-L-lysine chloromethyl ketone, and N-alpha -p-tosyl-L-arginine methyl ester were all obtained from Sigma (St. Louis, MO). Goat anti-mouse horseradish peroxidase-conjugated secondary antibody and enhanced chemiluminescence (ECL) reagents were from Amersham (Arlington Heights, IL). The cell culture media, sera, and antibiotics were from Life Technologies (Rockville, MD).

Cell culture. The rat parotid epithelial cell line Pa-4, also known as parotid C5 cells (26), was plated on Primaria culture dishes (Falcon) in Dulbecco's modified Eagle's/Ham's F-12 (1:1) medium supplemented with 2.5% fetal calf serum, insulin (5 µg/ml), transferrin (5 µg/ml), epidermal growth factor (25 ng/ml), hydrocortisone (1.1 µM), glutamate (5 mM), and kanamycin monosulfate (60 µg/ml) and was maintained in a humidified atmosphere of 5% CO2-95% air at 35°C. The Pa-4Delta Etk:ER cells were established by stably transfecting Pa-4 cells with Delta Etk:ER. The tyrosine kinase activity of Delta Etk:ER in Pa-4Delta Etk:ER cells can be further induced by the addition of 1 µM estrogen receptor agonist, beta -estradiol, to the culture medium, as demonstrated by the autophosphorylation of Tyr-566 of Etk (52). The Pa-4Delta Etk:ER cells were maintained with geneticin (G418; 600 µg/ml) and Dulbecco's modified Eagle's/Ham's F-12 (1:1, phenol red free) medium supplemented with 2.5% charcoal-stripped fetal calf serum plus the aforementioned ingredients. Madin-Darby canine kidney (MDCK) Delta Etk:ER cell clones were established and screened as described previously (52).

Measurements of TER. Epithelial cells were grown on permeable membranes (Clearwell; Costar-Corning, San Francisco, CA) that allow visual monitoring growth of polarized epithelial cells to confluence. Bioelectric parameters of cell monolayers were monitored at predesignated time intervals with a MilliCell ERS screening device (Millipore, Bedford, MA) that can measure spontaneous potential difference (SPD; expressed in mV, taking the apical aspect as reference) and TER (expressed in kOmega · cm2) with chopstick-style electrodes. Background potential difference (PD) arising from the asymmetry of voltage-sensing electrodes and electrical resistance contributed by both the bathing fluids and the filter membrane were measured and averaged by using the values observed at the beginning and end of each set of SPD and TER measurements from two blank filters bathed with the same medium utilized in cultivation of epithelial cells. These background PD and electrical resistance values were subtracted from the raw data of SPD and TER, respectively. With the use of the corrected SPD and TER, equivalent active ion transport rate (Ieq; equivalent short-circuit current) is estimated as SPD/TER, assuming the prevalence of Ohm's law for a given epithelial cell monolayer system.

Approximately 5-8 days after cell monolayers reached confluence, 1 µM estradiol (E2) was added 4 h before treatment with drug or hypoxia. For hypoxic treatment, cells grown on Clearwell were transferred to an exposure chamber, flushed with 1% O2 balanced with 5% CO2-94% N2, and sealed airtight. Measurements were obtained every 4 h during a total of 24 h of hypoxia, followed by 8 h of reoxygenation with 5% CO2 balanced with room air. Latrunculin B or genistein was added to the bathing fluids of cells cultured on the Clearwell. SPD and TER of these monolayers were measured at the indicated time intervals during drug treatment.

Confocal fluorescence microscopy. Pa-4 and Pa-4Delta Etk:ER cells were cultured and exposed to 1 µM E2 for 4 h before they were rinsed with Dulbecco's PBS (DPBS). For beta -catenin detection, cells were processed by following the procedures reported by Woo et al. (55). Briefly, cells were fixed with 2% paraformaldehyde in PBS, followed by exposure to PBS supplemented with 50 mM NH4Cl for 5 min, and then permeabilized for 10 min in PBS supplemented with 0.5% Triton X-100 (Tx-100) before being blocked and exposed to anti-beta -catenin antibody and an appropriate secondary antibody. Rhodamine-phalloidin was used to detect actin filaments. For analysis of the effects of hypoxia on F-actin and beta -catenin, confluent Pa-4 and Pa-4Delta Etk:ER cells were exposed to 1 µM estradiol for 4 h before being exposed to hypoxia for 16 h. Cells were then fixed and processed as described above for detection of F-actin and beta -catenin.

For detection of occludin, cells were fixed with 2% paraformaldehyde in PBS, exposed to PBS supplemented with 50 mM NH4Cl, and then permeabilized for 10-15 min with PBS containing 0.2% Tx-100 before being blocked and incubated with anti-occludin antibody and an appropriate secondary antibody (33). After processing, all slides were mounted in Prolong Antifade (Molecular Probes) and examined with a Nikon PCM Quantitative Measuring High-Performance Confocal System equipped with argon and green HeNe lasers attached to a Nikon TE300 Quantum inverted microscope. Images were acquired with Simple PCI C-Imaging Hardware and Quantitative Measuring Software and processed with Adobe Photoshop 5.0 (Adobe Systems, Mountain View, CA).

Isolation and Western blot analysis of soluble and insoluble protein fractions. Cells were cultured on petri dishes, exposed to 1 µM E2 for 4 h, and then washed twice with warm DPBS. These washed cells were incubated in a cell lysis buffer solution (pH 6.75) containing 0.1 M PIPES, 1 mM EGTA, 1 mM MgSO4, 2 M glycerol, 1% Tx-100, 1 mM PMSF, 1 µg/ml pepstatin A, 10 µg/ml N-tosyl-L-phenylalanine chloromethyl ketone, 1 µg/ml leupeptin, 1 mM sodium orthovanadate, 10 µg/ml N-alpha -p-tosyl-L-lysine chloromethyl ketone, and 10 µg/ml N-alpha -p-tosyl-L-arginine methyl ester for 10-15 min. Some experiments utilized the buffer above containing 0.1% Nonidet P-40 (NP-40) in place of Tx-100 to isolate detergent-soluble fractions (51). However, results were comparable when either detergent was used to isolate cytosol and detergent-soluble membranes. After the soluble (cytosolic and detergent-soluble membrane proteins) fraction of cell lysates was harvested by pipetting, the remaining cellular materials on the dish representing the insoluble fraction were scraped into RIPA composed of 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 1 mM PMSF, 20 µg/ml aprotinin, and 1 mM sodium orthovanadate in PBS. Unless indicated, equal amounts (between 10 and 30 µg) of soluble and insoluble fractions of cell lysates were diluted with 2× SDS sample buffer, resolved on 7.5% polyacrylamide gels, and electroblotted onto Immobilon-P (Millipore) or nitrocellulose membranes. Immunoprecipitation of Delta Etk:ER with an anti-ER antibody (HC-20; Santa Cruz Biotechnology, Santa Cruz, CA) was carried out as described previously (25), followed by immunoblot analyses using anti-phosphotyrosine antibody (4G10; Upstate Biotechnology). Blots were probed with appropriate primary antibodies (occludin, phosphotyrosine, or estrogen receptor) and goat anti-rabbit or anti-mouse secondary antibody, where appropriate, conjugated to horseradish peroxidase before visualization with an ECL detection system.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Activated Delta Etk:ER is translocated to a detergent insoluble pool. The Btk/Tec family of kinases is so far the only known tyrosine kinase family to carry an NH2-terminal PH domain. The versatile roles of Btk/Tec kinases are reflected by their protein-protein and protein-lipid interaction through the PH domain (for reviews, see Refs. 29 and 58). Accumulating evidence has suggested that PH domains of Btk/Tec family members are able to interact with F-actin (59). The actin cytoskeleton plays an essential role in a variety of cellular processes including cell division, shape, and motility, to name a few. Hence, we explored the possibility of translocation of Delta Etk:ER from the cytoplasm to the membrane upon its activation to further study the role of Etk activation in epithelial cell signaling.

It has been well established that Tx-100-insoluble fractions of cell lysates are enriched in cytoskeleton-associated proteins (53). Hence, resolution of Tx-100 soluble and insoluble fractions from Pa-4 and Pa-4Delta Etk:ER cell lysates offered an opportunity to examine the partitioning of Delta Etk:ER between these two fractions upon its activation. No Etk chimera was detectable in either the Tx-100-soluble or -insoluble fraction from Pa-4 cells, as expected (Fig. 1, top). The Delta Etk:ER chimera was detected in the Tx-100-insoluble fraction from unstimulated Pa-4Delta Etk:ER cells; however, proportionally more Delta Etk:ER was recovered in the Tx-100-soluble fraction, compared with the corresponding actin levels, which served as an internal control for extraction and sample loading (Fig. 1, bottom). After Etk chimera activation, the partition of Delta Etk:ER into the insoluble portion was markedly increased. Hence, there was an enhanced recruitment of Delta Etk:ER to the cytoskeleton and/or cytoskeletal proteins upon Etk activation, compared with nonactivated Etk. Most significantly, a substantial portion of the tyrosine-phosphorylated Delta Etk:ER protein was found in the insoluble pool of estradiol (E2)-treated Pa-4Delta Etk:ER cells (Fig. 1, middle). We reported previously that Etk activation renders tyrosine 566 autophosphorylation of the Etk chimera (52). Along this line, the Etk chimera detected in the insoluble fraction was extensively phosphorylated, reflecting Etk activation, compared with the corresponding Delta Etk:ER levels (Fig. 1, top). The increased recovery of Delta Etk:ER chimera in the insoluble fraction of stimulated Pa-4Delta Etk:ER cells was reproducible and is probably due to the enhanced stability of the activated Delta Etk:ER, similar to what we reported previously (52). Comparable redistribution of tyrosine-phosphorylated Etk chimera to the detergent-insoluble pool upon estradiol treatment was detected when NP-40 was utilized to resolve detergent soluble and insoluble fractions (data not shown). These observations suggest the intriguing possibility that the activated Etk in epithelial cells is translocated from the cytoplasm to the membrane fraction and acts as a functional modulator, in addition to governing proliferation and differentiation by gene regulation via STAT activation (52), of epithelial cell biology.


View larger version (33K):
[in this window]
[in a new window]
  		Fig. 1.   Activation of an inducible Etk-estrogen receptor (ER) chimeric construct (Delta Etk:ER) promotes translocation of the activated chimera to detergent-insoluble fractions. Cells treated with a vehicle (-) or 1 µM estradiol (E2) (+) were fractionated into detergent-soluble (S) and -insoluble (I) fractions as indicated. Equal amounts of fractionated lysates prepared from the same numbers of cells were immunoprecipitated with an anti-ER antibody, separated by SDS-PAGE, electroblotted to polyvinylidene difluoride membranes, and immunostained by respective antibodies against ERs (top) and phosphotyrosine (pTy; middle). The immunoblot with the actin antibody is also shown (bottom) as a loading control. Similar results were obtained from 6 independent experiments; 1 representative result is shown.

Phenotypic manifestation of epithelial cells that express Etk. To investigate the role of Etk in the regulation of epithelial cell physiology, both Pa-4Delta Etk:ER and parental Pa-4 cells were grown to form confluent monolayers on polyester Clearwell, and their TER values were measured. As shown in Fig. 2, TER in stably transfected and E2-stimulated Pa-4Delta Etk:ER as well as MDCKDelta Etk:ER epithelial cells reached a higher level than that in corresponding parental cells. The corresponding Ieq for E2-stimulated parental and Pa-4Delta Etk:ER cell monolayers were 1.85 ± 0.08 and 1.08 ± 0.09 µA/cm2, respectively. Because the measurements of both potential difference (SPD) and TER in MDCK cells were too low to give reproducible calculations of Ieq, the calculated Ieq values from MDCK and MDCKDelta Etk:ER cells are not shown. The observed difference in TER between parental and Etk-activated cells was persistent throughout an 8-day period of measurement (data not shown). This suggests tightening of the paracellular seals upon Etk activation. The TER of parental Pa-4 and MDCK cells are quite different in that Pa-4 cells exhibit intrinsically higher TER than do the MDCK cells (Fig. 2). Thus Etk activation enhances TER in epithelial barrier of either leaky or tight nature. The epithelial barrier to the diffusion of hydrophilic solutes through the paracellular pathway is afforded by TJ. Permeation across TJ is not static but is dynamically regulated under physiological environment and under pathophysiological conditions, such as hypoxia. In particular, epithelial cells have been reported to respond to hypoxic stress, rendering the depletion of ATP and causing the loss of TER (12).


View larger version (24K):
[in this window]
[in a new window]
  		Fig. 2.   Etk activation increases the transepithelial resistance (TER) of Pa-4 and Madin-Darby canine kidney (MDCK) cell monolayers. Cells were grown on semipermeable polyester Clearwell membranes until a confluent monolayer was established. E2 was added to the culture media at a final concentration of 1 µM 4 h before TER measurements were performed. Results represent means ± SE of 4 independent measurements performed in triplicate of E2-treated parental and Etk chimera stably transfected cells, respectively.

To probe the consequences of hypoxic stress in Pa-4Delta Etk:ER cells that possess the property of an elevated TER compared with the parental Pa-4 cells, we exposed both parental and Etk-activated Pa-4 cells to prolonged periods of hypoxia. During the first 8 h of hypoxic treatment, TER increased by ~30% and 20% above the control values in Pa-4 and Pa-4Delta Etk:ER cell monolayers, respectively (Fig. 3A). However, after 24 h of hypoxia, TER decreased drastically to ~5% of the normoxic levels in Pa-4 cells, whereas Pa-4Delta Etk:ER cells were able to maintain substantially higher TER, which was comparable to their normoxic controls. Even with the compromised TER, both Pa-4 and Pa-4Delta Etk:ER cells were mostly viable after 24 h of hypoxia, since TER values in both cells were restored back to the control levels at 4-8 h posthypoxia. These data showed that Etk activation sustains TER in epithelial cells under prolonged hypoxic conditions. The effects of Etk on TER and subsequent protection against hypoxic injury were unlikely to be unique to the Pa-4 cells, since Etk expression and activation in MDCK cells resulted in an enhancement of TER in a similar fashion (Fig. 2). Moreover, enhanced TER was sustained, as was seen in Pa-4Delta Etk:ER cell monolayers, in MDCKDelta Etk:ER cells over a 36-h period of hypoxia (data not shown). These data support the notion that Etk activation may be capable of augmenting tight junctional barrier function under pathophysiological conditions through a universal mechanism, directly or indirectly, in leaky and tight epithelial barriers. Because TJ integrity is disrupted by hypoxia in both Pa-4 and MDCK epithelial cells, it is suggested that Etk activation may prevent the hypoxia-induced TJ disruption in epithelial cells.


View larger version (20K):
[in this window]
[in a new window]
  		Fig. 3.   Relative changes in TER and equivalent active ion transport rate (Ieq) of Pa-4 and Pa-4Delta Etk:ER cell monolayers under hypoxic conditions. The Pa-4 and Pa-4Delta Etk:ER cells were cultured and treated as described in Fig. 1. TER (A) was measured, and the corresponding Ieq (B) was estimated (see text for details) at 0, 4, 8, and 24 h after the beginning of hypoxia treatment (1% O2). Data represent percentage changes compared with TER obtained from time 0, which is designated as 100%, normalized by the TER measured in the normoxia control. Results represent means ± SE of 4 independent measurements of E2-treated parental and Etk chimera stably transfected cells, respectively.

The Ieq of Pa-4 and Pa-4Delta Etk:ER monolayers was also determined. As shown in Fig. 3B, Ieq in Pa-4 cells decreased to almost zero after 24 h of hypoxia treatment, whereas ~60% of baseline Ieq remained in Pa-4Delta Etk:ER cells after the same period of hypoxic exposure. This suggests a beneficial effect of Etk on active ion transport. Because the measurement of TER is generally believed to be a reliable gauge of the junctional tightness between epithelial cells, we conducted further investigations utilizing TER measurement as a means to elucidate the role of Etk activation in epithelial cell biology.

Etk-induced enhancement of TER in response to hypoxia involves regulation of the actin cytoskeleton. One of the injurious effects of hypoxia on cells is to induce actin depolymerization (23, 37). Because the ability of the TJ to form a seal is dependent on the actin filaments organization (for a review, see Ref. 15), we investigated whether the hypoxia-induced reduction in TER might be mimicked by disassembly of actin and, further, whether Etk activation could preserve TER under conditions of actin filaments loss. Latrunculin B, an actin-depolymerizing agent (20), was utilized for this purpose.

As shown in Fig. 4, during 24-h treatment of latrunculin B, the TER values of E2-treated Pa-4 and Pa-4Delta Etk:ER cell monolayers decreased with time. However, the measured TER values from E2-treated Pa-4Delta Etk:ER cell monolayers were reproducibly and substantially higher than those of the parental cell monolayers after hypoxia treatment. Similar observations were also made in Pa-4 and Pa-4Delta Etk:ER cell monolayers when higher concentrations of latrunculin B at 0.1, 0.2, and 0.3 µM were used (data not shown). This observation is an extension of our previous notion that proper actin filament organization is essential for the assembly of functional barrier junctions. Moreover, Etk activation is capable of protecting Pa-4 cells from actin filament depolymerizing agent like latrunculin B. The data presented in Figs. 3 and 4 together suggested that Etk activation might in some way regulate the actin cytoskeletal elements involved in the formation of TJs and/or AJs in response to pathophysiological perturbations from hypoxia and/or latrunculin B. To further probe the effects of Etk expression and activation on the actin cytoskeleton, we characterized the organization and distribution of the cytoskeletal and junctional proteins known to mediate cell-cell contacts and paracellular seals in Pa-4 and Pa-4Delta Etk:ER cells.


View larger version (19K):
[in this window]
[in a new window]
  		Fig. 4.   Differential effect of latrunculin B on TER of Pa-4 and Pa-4Delta Etk:ER cell monolayers. The Pa-4 and Pa-4Delta Etk:ER cells were grown and treated with estradiol as described in Fig. 1. Latrunculin B (48 nM) was instilled into the culture media 4 h before the first measurement was performed. TER was measured at 4, 8, 12, and 24 h after latrunculin B was administered. Results represent means ± SE of 4 independent experiments performed in triplicate.

First, we examined the AJ components. After E2-treatment, Pa-4 and Pa-4Delta Etk:ER cell monolayers were fixed and processed for confocal fluorescence microscopy with the use of appropriate probes to detect the AJ components, beta -catenin and filamentous actin (F-actin). As shown in Fig. 5, the organization of both AJ components was profoundly affected by Etk activation. In Pa-4 cells, beta -catenin labeling (Fig. 5, green) was concentrated to a relatively diffuse but continuous boundary at and near the cell periphery. In contrast, Etk expression and activation resulted in redistribution of beta -catenin into a discrete network concentrated more at the cell periphery. Staining with rhodamine-phalloidin, which binds to F-actin (Fig. 5, red) demonstrated that F-actin in Pa-4 cells was organized primarily in internal stress fibers with some banding of filaments at the cell periphery. Pa-4Delta Etk:ER cells, on the other hand, exhibited a pronounced redistribution of F-actin to bundles localized at the cell periphery, an effect paralleled by an almost complete loss of internal stress fibers. While little colocalization of the diffuse beta -catenin network and the peripheral F-actin filaments was observed in the parental Pa-4 cells, coincident labeling of beta -catenin and F-actin at the Pa-4Delta Etk:ER cell periphery was evident after Etk activation. This redistribution of F-actin and beta -catenin was also accompanied by changes in shape of Pa-4Delta Etk:ER cells to a more uniformly polygonal configuration.


View larger version (113K):
[in this window]
[in a new window]
  		Fig. 5.   Etk activation elicits recruitment of beta -catenin and F-actin to the cell periphery. Pa-4 and Pa-4Delta Etk:ER cells were cultured and processed for immunofluorescence study as described in MATERIALS AND METHODS. After fixation, cells were probed with a mouse monoclonal antibody to beta -catenin, followed by a goat anti-mouse secondary antibody conjugated to FITC. Rhodamine-phalloidin was used to label F-actin. The distribution of beta -catenin (green) (top) and the organization of F-actin (red) (middle), as well as the colocalization of beta -catenin (green) and actin (red) (dual, bottom), are shown in Pa-4 and Pa-4Delta Etk:ER cells. Bar, 10 µm.

We also probed the effects of hypoxia on F-actin and beta -catenin distribution in cells with and without Etk activation. Hypoxia elicited effects on both beta -catenin (Fig. 6, green) and F-actin (Fig. 6, red) in Pa-4 and Pa-4Delta Etk:ER cells in the absence of estradiol. beta -catenin labeling in Pa-4 cells exposed to hypoxia exhibited a more uneven and disorganized labeling pattern around the cell periphery, relative to the more continuous but broad labeling pattern seen in the periphery of the Pa-4 cells without hypoxia (Fig. 5). The abundant stress fiber network normally present in Pa-4 cells was still detectable, although the filaments appeared truncated, and the intensity of F-actin labeling also appeared slightly diminished. Likewise, hypoxia resulted in the formation of a more discontinuous beta -catenin labeling pattern at the periphery of the Etk cells in the absence of estradiol. F-actin labeling also appeared less intense in these cells after hypoxia. Exposure of Pa-4 cells to estradiol before hypoxia did not change either of these labeling patterns. However, activation of the Delta Etk:ER construct with estradiol before the onset of hypoxia resulted in complete maintenance of the discrete and continuous F-actin/beta -catenin network concentrated at the cell periphery, similar to that shown in Fig. 5. These findings suggest that maintenance of the F-actin/beta -catenin network in response to hypoxic stress may be a major factor in maintenance of the epithelial barrier properties of cells containing the activated Delta Etk:ER construct. Together with the TER data, these findings establish a correlation, albeit possibly an indirect consequence, between the redistribution of AJ components and the maintenance of a tighter epithelial barrier during hypoxia and latrunculin B insult in cells with activated Etk.


View larger version (115K):
[in this window]
[in a new window]
  		Fig. 6.   Etk activation prevents the fragmentation of peripheral actin and beta -catenin elicited by hypoxia. Pa-4 and Pa-4Delta Etk:ER cells were exposed to hypoxia and then fixed and processed as described in MATERIALS AND METHODS for imaging of actin (red) and beta -catenin (green). After fixation, cells were probed with a mouse monoclonal antibody to beta -catenin, followed by a goat anti-mouse secondary antibody conjugated to FITC. Rhodamine-phalloidin was used to label F-actin. The distribution of these markers is shown in Pa-4 and Pa-4Delta Etk:ER cells exposed to hypoxia in the absence of estradiol (-E2) (top) and those exposed to 1 µM estradiol (+E2) for 4 h before hypoxia (bottom). Arrows indicate regions of discontinuity or disorganization of beta -catenin and F-actin at the cell peripheries. Bar, 10 µm.

Etk activation reduces the mobility of occludin on SDS-PAGE. To investigate whether comparable changes in elements of TJs were also elicited by Etk activation, we next examined the cellular distribution of tight junctional proteins, occludin, claudin, and ZO-1 in Etk-activated Pa-4Delta Etk:ER and parental Pa-4 cells. Immunofluorescence studies of these cell monolayers demonstrated that occludin was localized at the cell membrane in a comparable manner in both monolayers (Fig. 7). The tight junctional peripheral protein ZO-1 and the transmembrane protein claudin also exhibited a similar distribution in both Pa-4 and Pa-4Delta Etk:ER cells, where no marked changes in ZO-1 or claudin localization were detected as a result of Etk activation (data not shown). Hence, the localization of occludin, ZO-1, and claudin did not appear to be significantly modulated by Etk activation.


View larger version (64K):
[in this window]
[in a new window]
  		Fig. 7.   Etk activation does not alter occludin localization. Pa-4 and Pa-4Delta Etk:ER cells were probed with a mouse monoclonal antibody to occludin, followed by a goat anti-mouse secondary antibody conjugated to FITC. Rhodamine-phalloidin was used to label F-actin. The distribution of occludin alone (top) as well as the colocalization of occludin (green) and F-actin (red) in Pa-4 and Pa-4Delta Etk:ER cells (bottom) is shown. Bar, 15 µm.

Although the distribution of occludin remained unaltered after Etk activation, as shown by the immunofluorescence microscopy (Fig. 7), we explored the possibility that Etk activation might affect occludin properties, i.e., phosphorylation. Detergent-soluble and -insoluble protein fractions were prepared from Pa-4 and Pa-4Delta Etk:ER cells treated with 1 µM E2 for 4 h and resolved by SDS-PAGE, followed by Western blot analysis with a monoclonal antibody against occludin (Fig. 8). It has been well established that the mobility shifts of occludin detected on SDS-PAGE reflect occludin dephosphorylation/phosphorylation status (53). We utilized this technique as a means to evaluate occludin phosphorylation and assemblage status of TJs in our system. The detected occludin distributed between detergent-soluble and -insoluble pools and the observed multiple forms of occludin, in each pool, with different mobilities on SDS-PAGE would reflect effects mediated by Etk-dependent pathway(s) on TJ organization.


View larger version (28K):
[in this window]
[in a new window]
  		Fig. 8.   Occludin mobility on SDS-PAGE is increased as a result of Etk activation. Equal volumes of fractionated Nonidet P-40 (NP-40)-soluble (S) and -insoluble (I) lysates from the same numbers of cells were loaded onto a 7.5% SDS-PAGE gel, blotted onto nitrocellulose membranes, and probed with an antibody against occludin. One low-molecular-weight (LMW) form of occludin is present predominantly in Pa-4, but not Pa-4Delta Etk:ER, cells. Clusters of intermediate-molecular-weight (IMW) and high-molecular-weight (HMW) forms of occludin are present in detergent-soluble and -insoluble pools of lysates from Pa-4 and Pa-4Delta Etk:ER cells. Similar results were obtained from 6 independent experiments; 1 representative result is shown. Comparable effects were seen when detergent-soluble and -insoluble pools were isolated using Tx-100 rather than NP-40 (data not shown) and when samples were loaded according to equivalent protein content.

As shown in Fig. 8, occludin was present in both detergent-soluble and -insoluble pools prepared from Pa-4 and Pa-4Delta Etk:ER cells, and multiple forms of occludin were recognized by the occludin antibody, as reported previously (53). Results shown are from soluble and insoluble fractions resolved by NP-40; however, comparable effects were seen when soluble and insoluble fractions were resolved by Tx-100. Specifically, a low-molecular-weight (LMW) species at a relative molecular weight (Mr) of ~52 kDa, an intermediate-molecular-weight (IMW) species at an Mr of ~60 kDa, and a high-molecular-weight (HMW) species extending from 62 to ~68 kDa that was poorly resolved were present in both lysates. In Pa-4 cells, both LMW and IMW species were the primary forms of occludin detected in both detergent-soluble and -insoluble fractions. The HMW broad band of occludin, albeit less in quantity, was also detectable in the insoluble fraction in Pa-4 cells. In contrast, a pronounced decrease in the LMW form of occludin to almost undetectable levels was observed in stimulated Pa-4Delta Etk:ER cells (Fig. 8). The pronounced reduction in the mobility of occludin species detected in lysates prepared from treated Pa-4Delta Etk:ER cells suggested that the Etk-dependent cascade might have induced occludin phosphorylation, rendering slow-migrating forms of occludin on SDS-PAGE. Moreover, a substantial portion of occludin was present as the HMW mixtures between 62 and 68 kDa in the insoluble fraction of Pa-4Delta Etk:ER cells. This observation suggested that occludin located at the cell membrane might be mostly phosphorylated. Increased occludin phosphorylation, as reflected by the reduced mobility of HMW species on SDS-PAGE, has been linked to an enhanced assembly of occludin into functional TJs (36). The different intensities observed between the occludin recovered from insoluble fractions of Pa-4 and Pa-4Delta Etk:ER cells may have resulted from different sensitivity of individual occludin species to the antibody utilized in this study or different stability of individual species. The exact cause(s) leading to the increased occludin signals visualized in detergent-insoluble fractions of stimulated Pa-4Delta Etk:ER cells remains to be determined. However, our results unambiguously demonstrate that there is a marked shift of occludin from the LMW to IMW and/or HMW species upon Etk activation. Thus we propose that Etk activation may enhance occludin phosphorylation and, hence, the possible recruitment and/or stabilization of the existing occludin at the cell membrane to form more functional TJs, and as a result, increase TER (Fig. 2).

Increased TER after Etk activation is dependent on tyrosine kinase activity. Etk is a non-receptor tyrosine kinase. To establish the mechanistic role of Etk in the demonstrated enhancement of TER in Delta Etk:ER-transfected cells, as shown in Fig. 2, we utilized a widely used tyrosine kinase inhibitor, genistein (Fig. 9). Treatment of genistein caused decreases of TER in Pa-4, Pa-4Delta Etk:ER, and E2-stimulated Pa-4Delta Etk:ER cell monolayers over the 24-h measurements. The rate and extent of genistein-induced TER decreases were barely distinguishable between Pa-4 and Pa-4Delta Etk:ER monolayers in the absence of E2-treatment. However, decrease of TER in E2-activated Pa-4Delta Etk:ER cell monolayers in response to genistein at both 1 µM and 50 µM was more pronounced than in those cell monolayers without E2-activation (Fig. 9). Moreover, genistein-elicited TER decreases in both Pa-4 and Pa-4Delta Etk:ER cell monolayers, except for exposure to extremely high concentrations (e.g., 200 µM) of genistein, were reversible after 16 h of treatment (data not shown). Although genistein is not a specific Etk inhibitor , our results demonstrate that the catalytic activity of tyrosine kinase(s) is necessary to maintain TER in both Pa-4 and Pa-4Delta Etk:ER cell monolayers. The observation that Pa-4Delta Etk:ER cells (with E2) are more sensitive to genistein than the parental Pa-4 and Pa-4Delta Etk:ER cells (without E2) is also consistent with our hypothesis that Etk activation enhances epithelial barrier function and that Etk may be the critical tyrosine kinase involved in this signaling pathway in epithelial cells.


View larger version (24K):
[in this window]
[in a new window]
  		Fig. 9.   Increased TER observed with Etk activation is diminished by pretreatment with 1 µM (A) and 50 µM (B) genistein. Pa-4 and Pa-4Delta Etk:ER cell monolayers were grown and treated with E2 as described in Fig. 1. TER was measured at 4, 8, and 12 h after the indicated concentrations of genistein were administered. Data represent percentage changes compared with TER obtained at time 0, which is designated as 100%, normalized by the TER measured in corresponding cells maintained in genistein-free cultures. Similar results were obtained from 3 independent experiments; 1 representative result is shown. Values are means ± SE calculated from triplicate data.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We sought to develop a cell system that could serve as a useful model to provide insights into the function of Etk and to determine cellular events following Etk activation in both physiological and pathophysiological conditions. To this end, we demonstrated conclusively that Etk activation increases TER in both Pa-4 and MDCK epithelial cells under normoxia (Fig. 2). We also showed that prolonged hypoxia without reoxygenation results in a loss of TER and Ieq in the parental Pa-4 epithelial cells (Fig. 3). By contrast, Etk activation resulted in an enhanced TER and, thus, cell protection against injury from prolonged hypoxia, allowing the Pa-4Delta Etk:ER cells to maintain their TER and Ieq under hypoxic stress (Fig. 3).

The increased TER shown in Pa-4Delta Etk:ER cells was associated with changes in the organization and localization of components of AJs, including actin filaments and beta -catenin (Fig. 5). Moreover, the hypoxia-induced changes in F-actin and beta -catenin were prevented by prior activation of Etk. Although no prominent changes in cellular localization of constituents of TJs, such as occludin and ZO-1, were detected in Pa-4Delta Etk:ER (Fig. 7 ), the mobility of occludin prepared from Pa-4Delta Etk:ER cells was markedly reduced on SDS-PAGE (Fig. 8), suggesting that Etk activation renders increased occludin phosphorylation.

We also demonstrated that elements involved in the maintenance of TER in both Pa-4 and Pa-4Delta Etk:ER cells are sensitive to the treatment of a known tyrosine kinase inhibitor, genistein (Fig. 9). The literature on the role of tyrosine phosphorylation in TJ and AJ assembly/disassembly is somewhat controversial and inconclusive. For example, as epithelial cells reach confluence and undergo the process of contact inhibition, tyrosine phosphorylation of catenins decreases. This observed decrease in tyrosine phosphorylation in catenins is correlated with an increased association of tyrosine phosphatase activity (5, 11). Considerable circumstantial evidence also implicates tyrosine phosphorylation in the disassembly of cadherin-mediated cell-cell adhesion. Specifically, expression of constitutively activated v-Src oncoproteins, which induce tyrosine phosphorylation of beta - and p120-catenins and E-cadherin, leads to the loss or weakening of AJs (32, 41). However, very little information is available on the regulation of AJs by other tyrosine kinases such as Etk that may be more involved in the modulation of cell function, rather than proliferation and differentiation afforded by Src tyrosine kinase activation.

Occludin has been a prime target for a number of signaling pathways involved in the regulation of TJs, and the level of occludin tyrosine phosphorylation has been reported to be correlated with the TER level (8, 47). In these reports, increased occludin tyrosine phosphorylation is shown to be associated with the reassembly of TJs after ATP depletion and TJ restoration following "rescue" from Ras-mediated transformation in MDCK cells. We have now demonstrated by functional, immunocytochemical, and biochemical analyses that Etk-activated cascades enhance TJ/AJ assembly under normoxia and hypoxia. However, it is plausible that other phosphorylation targets in addition to occludin exist in the AJ and TJ complexes that may also be putative. The positioning of these junctions is coordinated and stabilized through an association with a continuous band of bundled actin filaments, known as an adhesion belt (27). However, it is unclear how the expression and function of each TJ and/or AJ molecule(s) are regulated to confer the overall epithelial barrier function. A profound Etk-induced reorganization of actin cytoskeleton into bundles of peripherally localized filaments may influence TER, as has been previously suggested (12, 22). In fact, we propose that reorganization and stabilization of actin filaments may be one of the principal functions of Etk, whether or not additional direct regulation of AJ or TJ components occurs. The proposal that Etk serves as a major regulator of actin cytoskeleton is derived from the observations of 1) the dramatically improved barrier function against hypoxic stress (Fig. 3), 2) the observed reorganization of F-actin and beta -catenin by Etk (Fig. 5), 3) the blockage of effects on F-actin and beta -catenin in cells exposed to hypoxia (Fig. 6), and 4) the preservation of TER from latrunculin B-treated Pa-4Delta Etk:ER cells (Fig. 4). Moreover, Btk, closely related to Etk, has been shown to colocalize with actin filaments upon stimulation (49, 59). In a separate study, the activated Bmx-green fluorescent protein (GFP) has been demonstrated to be localized in the membrane, while the resting Bmx-GFP is restricted to the cytoplasm (14), further supporting our notion.

Several studies have explored the relationship between hypoxia and disassembly of actin filaments. For instance, hypoxia induces dephosphorylation and activation of actin depolymerization factor (ADF)/cofilin, an actin regulatory protein that mediates cellular actin dynamics (37). Cofilin dephosphorylation is associated with acceleration of actin exchange on filament polymerization as well as loss of F-actin. Enhancing or preserving ADF/cofilin phosphorylation is, therefore, one way of preserving cellular F-actin. Recent work has implicated two LIM kinases in regulation of ADF/cofilin phosphorylation and actin dynamics: LIM- kinase 1 via a Rac-mediated pathway (1, 57) and LIM-kinase 2 via a Rho and/or Cdc42-mediated pathway (40). If Etk-induced protection from hypoxic injury involves prevention of ADF/cofilin-induced actin disassembly, this could occur either by direct activation of LIM-kinases or indirectly through actions on Rho-, Rac- or Cdc42-based signaling pathways. Etk may also act to alter effectors of actin filaments assembly other than ADF/cofilin. The membrane association of activated Etk also implicates the possibility that Etk is involved in Rho/Rac/Cdc42-mediated signaling pathways.

Hypoxic injury results in a disturbance in intra- and intercellular homeostasis ranging from the depletion of intracellular ATP to development of intracellular acidosis, decreased redox buffer capacity, and rearrangement of actin-based cytoskeleton (37). Theoretically, such processes could compromise the integrity of many epithelia, rendering an inability to function as an effective barrier to prevent leakages of small solutes to HMW proteins and to modulate the passage of inflammatory cells. For example, ATP depletion resulting from hypoxia or through usage of metabolic inhibitors in polarized epithelial cells has been demonstrated to cause perturbations in the actin cytoskeleton as well as disruption of TJ structures (38). Although several candidate genes and their regulatory mechanisms identified in response to oxidative stresses induced by intracellular oxygen radical production or cell penetration by oxidants are known, eukaryotic signal transduction and gene regulatory pathways that respond to hypoxia have only begun to unfold. In addition to altering epithelial cell behavior and function, hypoxia initiates a novel gene expression program (38) that culminates in a variety of changes in downstream events. Presumably, the balance between phosphorylation and dephosphorylation status is one of the means to render the ultimate biological manifestation as a result of hypoxia. However, little information on the kinase(s) or phosphatase(s) involved in hypoxia-related responses is available to date.

On the basis of our results, we hypothesize that the Etk activation in Pa-4 and also possibly in MDCK cells may "prime" these cells against hypoxic injury. In particular, Etk activation may upregulate the ATP-producing pathway(s) by improving their stoichiometric efficiency via phosphorylation/activation modalities or by inducing the expression of genes for ATP-supplying glycolytic enzymes. Alternatively, Etk activation may repress the activity or expression of the less required enzymes or pathways that consume ATP. These working hypotheses are consistent with our observations that 1) Ieq was sustained under prolonged hypoxic conditions in cells with activated Etk (Fig. 3B), 2) the injurious effect on TER elicited by latrunculin B was rapidly ameliorated by Etk activation (Fig. 4), and 3) the organization of actin-based cytoskeleton and the assembly of TJ were altered concomitantly with the augmentation of sealing function of TJs in the stimulated Pa-4Delta Etk:ER cells (Figs. 2, 3, and 8). Moreover, our preliminary results demonstrated that Etk activation enhances hypoxia-response element-dependent gene activation (C. Chau and D. K. Ann, unpublished observation), further supporting our notion. The reported role of Etk/Bmx protein in cell survival and apoptosis suggests rather complex functions for this protein. For example, Etk was shown to be essential for interleukin-6-induced neuroendocrine differentiation (34) and for protection against therapy-induced apoptosis (56) in prostate cancer cells. On the other hand, overexpression of Bmx in 32D myeloid progenitor cells resulted in apoptosis in the presence of granulocyte colony-stimulating factor, while cells expressing a kinase dead mutant of Bmx differentiated into mature granulocytes (14). Moreover, Bmx was shown to reconstitute apoptosis in Btk-deficient chicken B cells (44) and to link Src to STAT3 activation in Src-mediated cell transformation (45). Together, these findings imply that Etk/Bmx is more than likely to have distinct functions in different cell types, even in the same cell lineage during stages of development and differentiation or exposure to external environmental stimuli. In accordance with our present results, Etk/Bmx activation may be involved in modulating cell response to extreme environmental conditions, such as maintaining TER during prolonged hypoxic condition, in addition to regulating cell proliferation and differentiation.

In summary, this study provides the first direct evidence demonstrating that activated Etk enhances TER under resting conditions and that it sustains TER as well as maintains barrier function under prolonged hypoxia. On the basis of the data presented herein, we envision two potential signaling pathways by which Etk activation and its downstream events enhance and stabilize epithelial barrier function. As depicted in Fig. 10, we postulate that Etk restores epithelial TER properties by preventing the disassembly of intercellular TJ through a novel signaling pathway, even in the face of hypoxic insult. In the first pathway, tight junctional seal and, thus, TER are enhanced and/or maintained by Etk activation via stabilization of the actin cytoskeleton, as noted above. In the second pathway, in response to hypoxia, Etk acts directly on elements of TJs such as occludin to enhance TJ integrity. To our knowledge, this is the first report on a non-receptor tyrosine kinase, Etk, that enhances epithelial barrier function by biochemical modulation of TJ/AJ components in epithelial cells. Specific mechanisms and target proteins involved in the possible regulation of actin filaments and in the regulation of TJ by Etk activation remain future challenges.


View larger version (11K):
[in this window]
[in a new window]
  		Fig. 10.   A putative model for protection against the injurious effect of prolonged hypoxia on TER by Etk activation. A schematic presentation shows possible roles of Etk signaling in the enhancement of TER. At least 2 major pathways are involved: Etk activation leads to actin polymerization and/or prevents the disassembly of intercellular tight junctions under hypoxic conditions. The exact molecular mechanism by which Etk enhances TER and the downstream effector(s) of Etk remains to be established. TJ, tight junction.


    ACKNOWLEDGEMENTS

This work is supported in part by National Institutes of Health Grants DE-10742, EY-11386, HL-38658, HL-64365, and DK-48522 and by American Heart Association Grant-in-Aid 9950442N.


    FOOTNOTES

* A. Chang and Y. Wang contributed equally to this work.

Address for reprint requests and other correspondence: D. K. Ann, Univ. of Southern California, PSC-210B, Health Sciences Campus, 1985 Zonal Ave., Los Angeles, CA 90033 (E-mail: ann{at}hsc.usc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 16 November 2000; accepted in final form 12 February 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Arber, S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, and Caroni P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393: 805-809, 1998[Medline].

2.   Bacallao, R, Garfinkel A, Monke S, Zampighi G, and Mandel LJ. ATP depletion: a novel method to study junctional properties in epithelial tissues. I. Rearrangement of the actin cytoskeleton. J Cell Sci 107: 3301-3313, 1994[Abstract].

3.   Balda, MS, Gonzalez-Mariscal L, Contreras RG, Macias-Silva M, Torres-Marquez ME, Garcia-Sainz JA, and Cereijido M. Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J Membr Biol 122: 193-202, 1991[Web of Science][Medline].

4.   Balda, MS, Gonzalez-Mariscal L, Matter K, Cereijido M, and Anderson JM. Assembly of the tight junction: the role of diacylglycerol. J Cell Biol 123: 293-302, 1993[Abstract/Free Full Text].

5.   Brady-Kalnay, SM, Rimm DL, and Tonks NK. Receptor protein tyrosine phosphatase PTPµ associates with cadherins and catenins in vivo. J Cell Biol 130: 977-986, 1995[Abstract/Free Full Text].

6.   Buse, P, Woo PL, Alexander DB, Cha HH, Reza A, Sirota ND, and Firestone GL. Transforming growth factor-alpha abrogates glucocorticoid-stimulated tight junction formation and growth suppression in rat mammary epithelial tumor cells. J Biol Chem 270: 6505-6514, 1995[Abstract/Free Full Text].

7.   Canfield, PE, Geerdes AM, and Molitoris BA. Effect of reversible ATP depletion on tight-junction integrity in LLC-PK1 cells. Am J Physiol Renal Fluid Electrolyte Physiol 261: F1038-F1045, 1991[Abstract/Free Full Text].

8.   Chen, Y, Lu Q, Schneeberger EE, and Goodenough DA. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 11: 849-862, 2000[Abstract/Free Full Text].

9.   Christofori, G, and Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76, 1999[Web of Science][Medline].

10.   Collares-Buzato, CB, Jepson MA, Simmons NL, and Hirst BH. Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. Eur J Cell Biol 76: 85-92, 1998[Web of Science][Medline].

11.   Daniel, JM, and Reynolds AB. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 19: 883-891, 1997[Web of Science][Medline].

12.   Denker, BM, and Nigam SK. Molecular structure and assembly of the tight junction. Am J Physiol Renal Physiol 274: F1-F9, 1998[Abstract/Free Full Text].

13.   Doctor, RB, Bacallao R, and Mandel LJ. Method for recovering ATP content and mitochondrial function after chemical anoxia in renal cell cultures. Am J Physiol Cell Physiol 266: C1803-C1811, 1994[Abstract/Free Full Text].

14.   Ekman, N, Arighi E, Rajantie I, Saharinen P, Ristimaki A, Silvennoinen O, and Alitalo K. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner. Oncogene 19: 4151-4158, 2000[Web of Science][Medline].

15.   Fanning, AS, Mitic LL, and Anderson JM. Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 10: 1337-1345, 1999[Abstract/Free Full Text].

16.   Farshori, P, and Kachar B. Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells. J Membr Biol 170: 147-156, 1999[Web of Science][Medline].

17.   Fish, EM, and Molitoris BA. Alterations in epithelial polarity and the pathogenesis of disease states. N Engl J Med 330: 1580-1588, 1994[Free Full Text].

18.   Gibson, S, August A, Kawakami Y, Kawakami T, Dupont B, and Mills GB. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT. J Immunol 156: 2716-2722, 1996[Abstract].

19.   Gomez, S, del Mont Llosas M, Verdu J, Roura S, Lloreta J, Fabre M, and Garcia de Herreros A. Independent regulation of adherens and tight junctions by tyrosine phosphorylation in Caco-2 cells. Biochim Biophys Acta 1452: 121-132, 1999[Medline].

20.   Gronewold, TM, Sasse F, Lunsdorf H, and Reichenbach H. Effects of rhizopodin and latrunculin B on the morphology and on the actin cytoskeleton of mammalian cells. Cell Tissue Res 295: 121-129, 1999[Web of Science][Medline].

21.   Gumbiner, BM. Regulation of cadherin adhesive activity. J Cell Biol 148: 399-404, 2000[Abstract/Free Full Text].

22.   Hirokawa, N, and Tilney LG. Interactions between actin filaments and between actin filaments and membranes in quick-frozen and deeply etched hair cells of the chick ear. J Cell Biol 95: 249-261, 1982[Abstract/Free Full Text].

23.   Kellerman, PS, and Bogusky RT. Microfilament disruption occurs very early in ischemic proximal tubule cell injury. Kidney Int 42: 896-902, 1992[Web of Science][Medline].

24.   Kroshian, VM, Sheridan AM, and Lieberthal W. Functional and cytoskeletal changes induced by sublethal injury in proximal tubular epithelial cells. Am J Physiol Renal Fluid Electrolyte Physiol 266: F21-F30, 1994[Abstract/Free Full Text].

25.   Li, D, Lin HH, McMahon M, Ma H, and Ann DK. Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells. J Biol Chem 272: 25062-25070, 1997[Abstract/Free Full Text].

26.   Lin, HH, Tu ZJ, and Ann DK. Involvement of nuclear orphan receptor NGFI-B in transcriptional activation of salivary-specific R15 gene by cAMP. J Biol Chem 271: 27637-27644, 1996[Abstract/Free Full Text].

27.   Madara, JL. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 60: 143-159, 1998[Web of Science][Medline].

28.   Madara, JL, Parkos C, Colgan S, Nusrat A, Atisook K, and Kaoutzani P. The movement of solutes and cells across tight junctions. Ann NY Acad Sci 664: 47-60, 1992[Web of Science][Medline].

29.   Mano, H. The Tec family protein-tyrosine kinases: a subset of kinases for a subset of signalings. Int J Hematol 69: 6-12, 1999[Web of Science][Medline].

30.   Mano, H, Sato K, Yazaki Y, and Hirai H. Tec protein-tyrosine kinase directly associates with Lyn protein-tyrosine kinase through its N-terminal unique domain. Oncogene 9: 3205-3211, 1994[Web of Science][Medline].

31.   Martinez-Palomo, A, Meza I, Beaty G, and Cereijido M. Experimental modulation of occluding junctions in a cultured transporting epithelium. J Cell Biol 87: 736-745, 1980[Abstract/Free Full Text].

32.   Papkoff, J. Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src. J Biol Chem 272: 4536-4543, 1997[Abstract/Free Full Text].

33.   Penta, K, Varner JA, Liaw L, Hidai C, Schatzman R, and Quertermous T. Del1 induces integrin signaling and angiogenesis by ligation of alphaVbeta3. J Biol Chem 274: 11101-11109, 1999[Abstract/Free Full Text].

34.   Qiu, Y, Robinson D, Pretlow TG, and Kung HJ. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci USA 95: 3644-3649, 1998[Abstract/Free Full Text].

35.   Roura, S, Miravet S, Piedra J, Garcia de Herreros A, and Dunach M. Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J Biol Chem 274: 36734-36740, 1999[Abstract/Free Full Text].

36.   Sakakibara, A, Furuse M, Saitou M, Ando-Akatsuka Y, and Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137: 1393-1401, 1997[Abstract/Free Full Text].

37.   Schwartz, N, Hosford M, Sandoval RM, Wagner MC, Atkinson SJ, Bamburg J, and Molitoris BA. Ischemia activates actin depolymerizing factor: role in proximal tubule microvillar actin alterations. Am J Physiol Renal Physiol 276: F544-F551, 1999[Abstract/Free Full Text].

38.   Semenza, GL. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131: 207-214, 1998[Web of Science][Medline].

39.   Siliciano, JD, Morrow TA, and Desiderio SV. itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 89: 11194-11198, 1992[Abstract/Free Full Text].

40.   Sumi, T, Matsumoto K, Takai Y, and Nakamura T. Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2. J Cell Biol 147: 1519-15132, 1999[Abstract/Free Full Text].

41.   Takeda, H, Nagafuchi A, Yonemura S, Tsukita S, Behrens J, and Birchmeier W. V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and beta catenin is not required for the shift. J Cell Biol 131: 1839-1847, 1995[Abstract/Free Full Text].

42.   Takeda, H, and Tsukita S. Effects of tyrosine phosphorylation on tight junctions in temperature-sensitive v-src-transfected MDCK cells. Cell Struct Funct 20: 387-393, 1995[Web of Science][Medline].

43.   Tamagnone, L, Lahtinen I, Mustonen T, Virtaneva K, Francis F, Muscatelli F, Alitalo R, Smith CI, Larsson C, and Alitalo K. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 9: 3683-3688, 1994[Web of Science][Medline].

44.   Tomlinson, MG, Kurosaki T, Berson AE, Fujii GH, Johnston JA, and Bolen JB. Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk. J Biol Chem 274: 13577-13585, 1999[Abstract/Free Full Text].

45.   Tsai, YT, Su YH, Fang SS, Huang TN, Qiu Y, Jou YS, Shih HM, Kung HJ, and Chen RH. Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol Cell Biol 20: 2043-2054, 2000[Abstract/Free Full Text].

46.   Tsukada, S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, and Witte ON. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72: 279-290, 1993[Web of Science][Medline].

47.   Tsukamoto, T, and Nigam SK. Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am J Physiol Renal Physiol 276: F737-F750, 1999[Abstract/Free Full Text].

48.   Tsukamoto, T, and Nigam SK. Tight junction proteins form large complexes and associate with the cytoskeleton in an ATP depletion model for reversible junction assembly. J Biol Chem 272: 16133-16139, 1997[Abstract/Free Full Text].

49.   Varnai, P, Rother KI, and Balla T. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells. J Biol Chem 274: 10983-10989, 1999[Abstract/Free Full Text].

50.   Vetrie, D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, Edvard Smith CI, and Bentley DR. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361: 226-233, 1993[Medline].

51.   Vilalta, PM, Zhang L, and Hamm-Alvarez SF. A novel taxol-induced vimentin phosphorylation and stabilization revealed by studies on stable microtubules and vimentin intermediate filaments. J Cell Sci 111: 1841-1852, 1998[Abstract].

52.   Wen, X, Lin HH, Shih HM, Kung HJ, and Ann DK. Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate STAT-mediated gene expression in salivary and lung epithelial cells. J Biol Chem 274: 38204-38210, 1999[Abstract/Free Full Text].

53.   Wong, V. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol Cell Physiol 273: C1859-C1867, 1997[Abstract/Free Full Text].

54.   Woo, PL, Cha HH, Singer KL, and Firestone GL. Antagonistic regulation of tight junction dynamics by glucocorticoids and transforming growth factor-beta in mouse mammary epithelial cells. J Biol Chem 271: 404-412, 1996[Abstract/Free Full Text].

55.   Woo, PL, Ching D, Guan Y, and Firestone GL. Requirement for Ras and phosphatidylinositol 3-kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial electrical resistance in mammary tumor cells. J Biol Chem 274: 32818-32828, 1999[Abstract/Free Full Text].

56.   Xue, LY, Qiu Y, He J, Kung HJ, and Oleinick NL. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin. Oncogene 18: 3391-3398, 1999[Web of Science][Medline].

57.   Yang, N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, and Mizuno K. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393: 809-812, 1998[Medline].

58.   Yang, WC, Collette Y, Nunes JA, and Olive D. Tec kinases: a family with multiple roles in immunity. Immunity 12: 373-382, 2000[Web of Science][Medline].

59.   Yao, L, Janmey P, Frigeri LG, Han W, Fujita J, Kawakami Y, Apgar JR, and Kawakami T. Pleckstrin homology domains interact with filamentous actin. J Biol Chem 274: 19752-19761, 1999[Abstract/Free Full Text].

Am J Physiol Cell Physiol 280(6):C1657-C1668
0363-6143/01 $5.00 Copyright © 2001 the American Physiological Society


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. R. Wilson, M. E. Goddard, K. P. O'Dea, S. Choudhury, and M. Takata
Differential roles of p55 and p75 tumor necrosis factor receptors on stretch-induced pulmonary edema in mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L60 - L68.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. D. Gultice, K. L. Selesniemi, and T. L. Brown
Hypoxia Inhibits Differentiation of Lineage-Specific Rcho-1 Trophoblast Giant Cells
Biol Reprod, June 1, 2006; 74(6): 1041 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H.-V. Nguyen, J.-L. Chen, J. Zhong, K.-J. Kim, E. D. Crandall, Z. Borok, Y. Chen, and D. K. Ann
SUMOylation Attenuates Sensitivity toward Hypoxia- or Desferroxamine-Induced Injury by Modulating Adaptive Responses in Salivary Epithelial Cells
Am. J. Pathol., May 1, 2006; 168(5): 1452 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C. H. Chau, C. A. Clavijo, H.-T. Deng, Q. Zhang, K.-J. Kim, Y. Qiu, A. D. Le, and D. K. Ann
Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systems
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C444 - C454.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
K. Paavonen, N. Ekman, M. Wirzenius, I. Rajantie, M. Poutanen, and K. Alitalo
Bmx Tyrosine Kinase Transgene Induces Skin Hyperplasia, Inflammatory Angiogenesis, and Accelerated Wound Healing
Mol. Biol. Cell, September 1, 2004; 15(9): 4226 - 4233.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Vargas, B. F. Nore, A. Berglof, J. E. Heinonen, P. T. Mattsson, C. I. E. Smith, and A. J. Mohamed
Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx
J. Biol. Chem., March 8, 2002; 277(11): 9351 - 9357.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. G. Morgan
Nonmuscle Motility/Cytoskeleton
Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1634 - C1635.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamm-Alvarez, S. F.
Right arrow Articles by Ann, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamm-Alvarez, S. F.
Right arrow Articles by Ann, D. K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online